Clinical Trials on Mild Moderate in Australia
Total 80 results
-
Delenex Therapeutics AGCompletedMild-to-moderate Psoriasis VulgarisAustria, Germany
-
Actinogen MedicalRecruitingAlzheimer Disease | Dementia, Mild | Dementia ModerateAustralia
-
KoBioLabsNovotech (Australia) Pty LimitedCompletedModerate to Severe AsthmaAustralia
-
Medical University of ViennaCompletedDepressive; Episode, Major | Recurrent Depressive Disorder, Current Episode Moderate | Recurrent Depressive Disorder, Current Episode MildAustria
-
Croma-Pharma GmbHCompleted
-
Cognition TherapeuticsNational Institute on Aging (NIA)Active, not recruitingMild to Moderate Alzheimer's DiseaseUnited States, Australia, Netherlands, Czechia, Spain
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessAustralia, Canada, United Kingdom
-
Kythera BiopharmaceuticalsCompletedPhase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat (ATX-101)Moderate or Severe Submental FullnessUnited Kingdom, Canada, Australia
-
University of Western SydneyCompletedMild Cognitive Impairment | Mild DementiaHong Kong, Australia
-
Société des Produits Nestlé (SPN)Completed
-
PharmatrophiX Inc.National Institute on Aging (NIA)CompletedMild to Moderate Alzheimer's DiseaseSpain, Germany, Austria, Czechia, Sweden
-
University of Western SydneyActive, not recruitingMild Cognitive Impairment | Mild Dementia | Healthy Older AdultsAustralia
-
Monash UniversityTurning PointCompletedCannabis Use Disorder, Moderate | Cannabis Use Disorder, SevereAustralia
-
Actinogen MedicalAvance ClinicalCompletedMild Cognitive Impairment | Alzheimer's DiseaseAustralia
-
The George InstituteChinese University of Hong Kong; Monash University; The Alfred; University of Sydney and other collaboratorsRecruitingNeurocognitive Impairment, MildAustralia
-
The University of New South WalesCompletedMild Cognitive ImpairmentAustralia
-
Neuroscience Trials AustraliaThe Florey Institute of Neuroscience and Mental HealthActive, not recruitingMild Cognitive Impairment | Prodromal Alzheimer's Disease | Mild Alzheimer's DiseaseAustralia
-
ANSwers Neuroscience, Inc.WithdrawnMild Traumatic Brain Injury | Concussion, MildAustralia
-
AllerganCompletedMid-face Volume DeficiencyAustralia
-
Headsafe MFGRecruiting
-
Sun Pharmaceutical Industries LimitedActive, not recruitingChronic Plaque Psoriasis | Moderate to Severe Nail PsoriasisUnited States, Australia
-
Bayside HealthCompletedMild Cognitive Impairment | Alzheimer's DiseaseAustralia
-
University of East AngliaUniversity of Illinois at Chicago; Swinburne University of TechnologyCompletedMild Cognitive Impairment | Subjective Memory ImpairmentUnited States, Australia, United Kingdom
-
Debiopharm International SACompletedModerate Alzheimer's DiseaseAustralia, Canada, United Kingdom
-
Medical University of GrazRecruiting
-
Jiangsu HengRui Medicine Co., Ltd.CompletedModerate-to-severe Chronic Plaque PsoriasisUnited States, Australia, China
-
Life Molecular Imaging SACompletedAlzheimer Disease | Amyloid Beta-ProteinAustralia
-
The University of QueenslandJohns Hopkins University; Royal Brisbane and Women's Hospital; Queensland University... and other collaboratorsRecruitingParkinson Disease | Mild Cognitive Impairment | Memory ImpairmentAustralia
-
Janssen-Cilag Pty LtdCompleted
-
University of SydneyCompletedSleep Wake Disorders | Insomnia | Cognitive Dysfunction | Mild Cognitive Impairment | Cognitive DisorderAustralia
-
Atridia Pty Ltd.RecruitingAlzheimer's Disease (AD)Australia
-
Novartis PharmaceuticalsCompletedModerate and Severe Plaque PsoriasisUnited States, Argentina, Germany, Belgium, Italy, United Kingdom, Turkey, Guatemala, Australia
-
Croma-Pharma GmbHProinnovera GmbHCompletedMid Face Volume DeficitAustria
-
Medical University of ViennaRecruitingHealthy | Alzheimer Disease | Mild Cognitive ImpairmentAustria
-
Merck Sharp & Dohme LLCCompletedMild Cognitive Impairment | Alzheimer's DiseaseUnited States, Australia
-
Harald Wolf, MDMedical Scientific Fund of the Mayor of ViennaCompletedBrain Injuries, TraumaticAustria
-
Bausch Health Americas, Inc.TerminatedModerate to Severe Plaque PsoriasisUnited States, Austria, France, Poland, Australia, Czechia, Canada, Hungary, Portugal, Spain, Netherlands
-
Inmune Bio, Inc.RecruitingMental Disorders | Brain Diseases | Central Nervous System Diseases | Nervous System Diseases | Neurocognitive Disorders | Neurodegenerative Diseases | Dementia | Alzheimer Disease | Tauopathies | Mild Cognitive ImpairmentAustralia, Canada, United Kingdom, Poland, Germany
-
Novartis PharmaceuticalsCompletedModerate to Severe Nail PsoriasisGermany, Belgium, Spain, United States, Australia, United Kingdom, Denmark, Czechia, Greece
-
Humanigen, Inc.CompletedModerate-to-Severe AsthmaFrance, United Kingdom, United States, Australia, Poland, Ukraine
-
TakedaZinfandel Pharmaceuticals Inc.TerminatedMild Cognitive Impairment Due to Alzheimer's DiseaseUnited States, Germany, Switzerland, United Kingdom, Australia
-
Medical University of GrazMedical University InnsbruckRecruitingAmyloid Cardiomyopathy | Wild Type ATTR AmyloidosisAustria
-
TakedaTerminatedMild Cognitive Impairment Due to Alzheimer's DiseaseUnited States, Australia, United Kingdom, Switzerland
-
Novartis PharmaceuticalsCompletedModerate to Severe Palmoplantar PsoriasisBelgium, United States, Hungary, Russian Federation, Turkey, Australia, Israel, Netherlands, Portugal, Spain, United Kingdom, Norway, Slovakia, Canada, Finland
-
Arbeitsgemeinschaft medikamentoese TumortherapieAmgenTerminatedKRAS Wild Type | Resectable Type II Gastric AdenocarcinomaAustria
-
Centre Hospitalier Universitaire VaudoisUnknownHematologic Diseases | Hematologic Malignancy | Invasive Mold Infections | Breakthrough Invasive Mold InfectionsSwitzerland, Austria, Germany
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Plaque PsoriasisUnited States, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Italy, Spain, Sweden, Switzerland, United Kingdom
-
UCB Biopharma SRLCompletedModerate to Severe Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, Taiwan
-
Suzhou Connect Biopharmaceuticals, Ltd.CompletedModerate-to-severe Atopic DermatitisUnited States, Australia, China, New Zealand